BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12727817)

  • 21. Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors.
    Cui P; Tomsig JL; McCalmont WF; Lee S; Becker CJ; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1634-40. PubMed ID: 17257836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal.
    Ferry G; Giganti A; Cogé F; Bertaux F; Thiam K; Boutin JA
    FEBS Lett; 2007 Jul; 581(18):3572-8. PubMed ID: 17628547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pharmacology of adipocyte-secreted autotaxin.
    Moulharat N; Fould B; Giganti A; Boutin JA; Ferry G
    Chem Biol Interact; 2008 Mar; 172(2):115-24. PubMed ID: 18282564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease.
    Dennis J; Nogaroli L; Fuss B
    J Neurosci Res; 2005 Dec; 82(6):737-42. PubMed ID: 16267828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study on expression of autotaxin mRNA in hepatocellular carcinoma].
    Zhao Z; Xu S; Zhang G
    Zhonghua Gan Zang Bing Za Zhi; 1999 Sep; 7(3):140-1. PubMed ID: 10572678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation and biological activities of the autotaxin-LPA axis.
    van Meeteren LA; Moolenaar WH
    Prog Lipid Res; 2007 Mar; 46(2):145-60. PubMed ID: 17459484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an activity-based probe for autotaxin.
    Cavalli S; Houben AJ; Albers HM; van Tilburg EW; de Ru A; Aoki J; van Veelen P; Moolenaar WH; Ovaa H
    Chembiochem; 2010 Nov; 11(16):2311-7. PubMed ID: 20941725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells.
    Lee HY; Murata J; Clair T; Polymeropoulos MH; Torres R; Manrow RE; Liotta LA; Stracke ML
    Biochem Biophys Res Commun; 1996 Jan; 218(3):714-9. PubMed ID: 8579579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells.
    Jansen S; Andries M; Vekemans K; Vanbilloen H; Verbruggen A; Bollen M
    Cancer Lett; 2009 Nov; 284(2):216-21. PubMed ID: 19482419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin.
    Clair T; Koh E; Ptaszynska M; Bandle RW; Liotta LA; Schiffmann E; Stracke ML
    Lipids Health Dis; 2005 Feb; 4():5. PubMed ID: 15737239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysophosphatidic acid signaling: how a small lipid does big things.
    Luquain C; Sciorra VA; Morris AJ
    Trends Biochem Sci; 2003 Jul; 28(7):377-83. PubMed ID: 12878005
    [No Abstract]   [Full Text] [Related]  

  • 32. Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties.
    Yuelling LM; Fuss B
    Biochim Biophys Acta; 2008 Sep; 1781(9):525-30. PubMed ID: 18485925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells.
    Seifert A; Klonisch T; Wulfaenger J; Haag F; Dralle H; Langner J; Hoang-Vu C; Kehlen A
    Oncol Rep; 2008 Jun; 19(6):1485-91. PubMed ID: 18497954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.
    van Meeteren LA; Brinkmann V; Saulnier-Blache JS; Lynch KR; Moolenaar WH
    Cancer Lett; 2008 Aug; 266(2):203-8. PubMed ID: 18378389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scalable purification and characterization of the extracellular domain of human autotaxin from prokaryotic cells.
    Haga A; Hashimoto K; Tanaka N; Nakamura KT; Deyashiki Y
    Protein Expr Purif; 2008 May; 59(1):9-17. PubMed ID: 18249559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An essential oligomannosidic glycan chain in the catalytic domain of autotaxin, a secreted lysophospholipase-D.
    Jansen S; Callewaert N; Dewerte I; Andries M; Ceulemans H; Bollen M
    J Biol Chem; 2007 Apr; 282(15):11084-91. PubMed ID: 17307740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of autotaxin and other motility stimulating factors in the regulation of tumor cell motility.
    Stracke M; Liotta LA; Schiffmann E
    Symp Soc Exp Biol; 1993; 47():197-214. PubMed ID: 8165565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of a pipemidic acid autotaxin inhibitor.
    Hoeglund AB; Bostic HE; Howard AL; Wanjala IW; Best MD; Baker DL; Parrill AL
    J Med Chem; 2010 Feb; 53(3):1056-66. PubMed ID: 20041668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities.
    Clair T; Lee HY; Liotta LA; Stracke ML
    J Biol Chem; 1997 Jan; 272(2):996-1001. PubMed ID: 8995394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.
    Ferry G; Tellier E; Try A; Grés S; Naime I; Simon MF; Rodriguez M; Boucher J; Tack I; Gesta S; Chomarat P; Dieu M; Raes M; Galizzi JP; Valet P; Boutin JA; Saulnier-Blache JS
    J Biol Chem; 2003 May; 278(20):18162-9. PubMed ID: 12642576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.